Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pliant Therapeutics Inc (PLRX)

Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Why Shares of Pliant Therapeutics Are Rising Tuesday

The company's lead therapy fared well in a phase 2a trial to treat two separate conditions.

PLRX : 14.90 (+2.41%)
Pliant Therapeutics, Inc. (PLRX) Reports Q1 Loss, Misses Revenue Estimates

Pliant Therapeutics, Inc. (PLRX) delivered earnings and revenue surprises of -1.52% and 31.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

PLRX : 14.90 (+2.41%)
BOLT : 1.4000 (+14.75%)
Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates

Cardiff Oncology (CRDF) delivered earnings and revenue surprises of -8.70% and 10.67%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

CRDF : 5.34 (-7.13%)
PLRX : 14.90 (+2.41%)
Pliant Therapeutics, Inc. (PLRX) Reports Q4 Loss, Tops Revenue Estimates

Pliant Therapeutics, Inc. (PLRX) delivered earnings and revenue surprises of -2.86% and 27.10%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

PLRX : 14.90 (+2.41%)
CRMD : 4.24 (+1.92%)
Codexis (CDXS) Reports Q4 Loss, Tops Revenue Estimates

Codexis (CDXS) delivered earnings and revenue surprises of 17.39% and 4.30%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

CDXS : 3.49 (-0.57%)
PLRX : 14.90 (+2.41%)
Techne (TECH) Q2 Earnings and Revenues Miss Estimates

Techne (TECH) delivered earnings and revenue surprises of -4.08% and 6.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

TECH : 70.39 (+1.40%)
PLRX : 14.90 (+2.41%)
Why Pliant Therapeutics Stock Is Skyrocketing This Week

The company's experimental idiopathic pulmonary fibrosis drug is showing a lot of promise.

PLRX : 14.90 (+2.41%)
Biotech Stock Roundup: BLUE Down on Share Issuance, CPRX Falls on Generic Filing & More

Updates from bluebird (BLUE) and Catalyst Pharmaceuticals (CPRX) are the key highlights from the biotech sector during the past week.

CPRX : 15.94 (-2.03%)
BLUE : 1.2800 (-6.23%)
AXLA : 0.4009 (-8.89%)
PLRX : 14.90 (+2.41%)
Pliant Therapeutics (PLRX) Surges 44% in A Week: Here's Why

Shares of Pliant Therapeutics (PLRX) have been rising since management reported positive interim data from a mid-stage study evaluating a higher dose of its lead pipeline candidate in IPF patients.

ADCT : 4.49 (+6.90%)
RCUS : 18.88 (+3.68%)
ETON : 3.75 (-1.32%)
PLRX : 14.90 (+2.41%)
Pliant Therapeutics Gaps 34% Higher: More Upside To Come?

Pliant Therapeutics zoomed 34% higher and added to that gain in the next session.This followed good news about clinical trials for a lung-condition treatment.

PLRX : 14.90 (+2.41%)
NVS : 96.73 (+0.89%)
CPRX : 15.94 (-2.03%)
NBIX : 137.92 (+0.07%)

Barchart Exclusives

What The USDA Prospective Plantings Report Means For Grains
Taking a look at the USDA Prospective Plantings report, what was surprising and why it opens the door to speculators reevaluating risk. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar